RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eckert & Ziegler Stock

Eckert & Ziegler Revenue 2024

Eckert & Ziegler Revenue

275.28 M EUR

Ticker

EUZ.DE

ISIN

DE0005659700

WKN

565970

In 2024, Eckert & Ziegler's sales reached 275.28 M EUR, a 11.86% difference from the 246.09 M EUR sales recorded in the previous year.

The Eckert & Ziegler Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2026e324.5635,85
2025e294.6739,48
2024e275.2842,26
2023246.0947,28
2022222.2348,04
2021180.4450,48
2020176.1449,13
2019178.4948,75
2018168.7144,14
2017138.6346,07
2016137.9447,94
2015139.7544,98
2014127.2650,12
2013117.146,29
201212052,17
2011116.253,70
2010111.150,86
2009101.450,39
200871.647,77
20075549,82
200650.447,42
200541.844,26
200435.545,92

Eckert & Ziegler Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eckert & Ziegler, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eckert & Ziegler from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eckert & Ziegler’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eckert & Ziegler. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eckert & Ziegler’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eckert & Ziegler’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eckert & Ziegler’s growth potential.

Eckert & Ziegler Revenue, EBIT and net profit per share

DateEckert & Ziegler RevenueEckert & Ziegler EBITEckert & Ziegler Net Income
2026e324.56 M undefined72.37 M undefined52.53 M undefined
2025e294.67 M undefined60.15 M undefined42.11 M undefined
2024e275.28 M undefined55.45 M undefined37.9 M undefined
2023246.09 M undefined44.2 M undefined26.3 M undefined
2022222.23 M undefined42.12 M undefined29.28 M undefined
2021180.44 M undefined30.39 M undefined34.53 M undefined
2020176.14 M undefined28.74 M undefined21.29 M undefined
2019178.49 M undefined29.53 M undefined22.02 M undefined
2018168.71 M undefined20.01 M undefined16.13 M undefined
2017138.63 M undefined15.5 M undefined14.7 M undefined
2016137.94 M undefined11.85 M undefined9.55 M undefined
2015139.75 M undefined5.93 M undefined10.72 M undefined
2014127.26 M undefined11.27 M undefined6.78 M undefined
2013117.1 M undefined11.9 M undefined9.1 M undefined
2012120 M undefined19.8 M undefined10.3 M undefined
2011116.2 M undefined22.8 M undefined10.4 M undefined
2010111.1 M undefined18.5 M undefined9.4 M undefined
2009101.4 M undefined19.9 M undefined13.3 M undefined
200871.6 M undefined11.6 M undefined4.5 M undefined
200755 M undefined6 M undefined1.9 M undefined
200650.4 M undefined5.9 M undefined2.2 M undefined
200541.8 M undefined2.5 M undefined1.6 M undefined
200435.5 M undefined3.4 M undefined3.3 M undefined

Eckert & Ziegler stock margins

The Eckert & Ziegler margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eckert & Ziegler. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eckert & Ziegler.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eckert & Ziegler's sales revenue. A higher gross margin percentage indicates that the Eckert & Ziegler retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eckert & Ziegler's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eckert & Ziegler's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eckert & Ziegler's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eckert & Ziegler. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eckert & Ziegler's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eckert & Ziegler Margin History

Eckert & Ziegler Gross marginEckert & Ziegler Profit marginEckert & Ziegler EBIT marginEckert & Ziegler Profit margin
2026e47.28 %22.3 %16.18 %
2025e47.28 %20.41 %14.29 %
2024e47.28 %20.14 %13.77 %
202347.28 %17.96 %10.69 %
202248.04 %18.95 %13.17 %
202150.48 %16.84 %19.14 %
202049.13 %16.32 %12.09 %
201948.75 %16.55 %12.34 %
201844.14 %11.86 %9.56 %
201746.07 %11.18 %10.6 %
201647.94 %8.59 %6.92 %
201544.98 %4.24 %7.67 %
201450.12 %8.86 %5.32 %
201346.29 %10.16 %7.77 %
201252.17 %16.5 %8.58 %
201153.7 %19.62 %8.95 %
201050.86 %16.65 %8.46 %
200950.39 %19.63 %13.12 %
200847.77 %16.2 %6.28 %
200749.82 %10.91 %3.45 %
200647.42 %11.71 %4.37 %
200544.26 %5.98 %3.83 %
200445.92 %9.58 %9.3 %

Eckert & Ziegler Aktienanalyse

What does Eckert & Ziegler do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Eckert & Ziegler's Sales Figures

The sales figures of Eckert & Ziegler originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Eckert & Ziegler’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Eckert & Ziegler's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Eckert & Ziegler’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Eckert & Ziegler stock

How much revenue did Eckert & Ziegler generate this year?

Eckert & Ziegler has achieved a revenue of 275.28 M EUR this year.

How much was the turnover of the company Eckert & Ziegler compared to the previous year?

The revenue of Eckert & Ziegler has increased by 11.86% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Eckert & Ziegler?

The revenue of Eckert & Ziegler is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Eckert & Ziegler measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Eckert & Ziegler so important for investors?

The revenue of Eckert & Ziegler is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Eckert & Ziegler pay?

Over the past 12 months, Eckert & Ziegler paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.17 %. For the coming 12 months, Eckert & Ziegler is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler?

The current dividend yield of Eckert & Ziegler is 1.17 %.

When does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler?

Eckert & Ziegler paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.28 %.

In which sector is Eckert & Ziegler located?

Eckert & Ziegler is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler in the year 2023?

In the year 2023, Eckert & Ziegler distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler pay out the dividend?

The dividends of Eckert & Ziegler are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eckert & Ziegler stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eckert & Ziegler

Our stock analysis for Eckert & Ziegler Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.